Surgical Robots Market 2030: The Future of Surgery in Developing Economies

Comments · 3 Views

The global surgical robots market was valued at approximately USD 3.92 billion in 2023 and is forecasted to grow at a compound annual growth rate (CAGR) of 9.5% from 2024 to 2030.

The global surgical robots market was valued at approximately USD 3.92 billion in 2023 and is forecasted to grow at a compound annual growth rate (CAGR) of 9.5% from 2024 to 2030. Several factors are contributing to this robust market expansion, including a global shortage of physicians and surgeons, the increasing use of automated surgical instruments, and the rising prevalence of bone degenerative diseases. These factors are creating a significant demand for advanced robotic surgical systems to improve precision and efficiency in surgical procedures.

One of the key drivers of market growth is the growing shortage of healthcare professionals, particularly surgeons. As the global population ages and healthcare demands increase, there is a pressing need for more efficient surgical solutions. Surgical robots help address this issue by enabling greater automation, reducing the reliance on human intervention, and improving overall surgical outcomes. The adoption of robotic systems allows for more minimally invasive procedures, leading to quicker recovery times, reduced complications, and enhanced surgical precision.

Gather more insights about the market drivers, restrains and growth of the Surgical Robots Market

In addition, the increasing prevalence of bone degenerative diseases, especially conditions like arthritis and osteoporosis, is expected to further drive the demand for surgical robots. These diseases often lead to the need for joint replacement surgeries, particularly hip and knee replacements. According to the Agency for Healthcare Research and Quality, over 450,000 hip replacement surgeries are performed annually in the U.S. alone, a trend that is expected to continue to rise as the aging population increases.

The surge in the number of knee and hip replacement surgeries is a particularly significant factor that is anticipated to drive the widespread adoption of robotic-assisted surgery. These surgeries are typically required to address disorders such as various types of arthritis, degenerative bone diseases, and osteoporosis, all of which are becoming more common as the global population ages. The growing incidence of these conditions is resulting in a larger patient population requiring surgical interventions, which, in turn, is pushing healthcare systems to adopt more efficient, precise, and minimally invasive surgical technologies, such as surgical robots.

Regional Insights

In 2023, North America held the largest share of the global surgical robots market, accounting for 49.9% of the total market. This dominant position can be attributed to several key factors, including significant improvements in surgical procedures and healthcare facilities catering to a wide range of disorders. Robotic-assisted surgeries in North America have been increasingly adopted due to their proven advantages over traditional open surgeries, such as higher success rates and better patient outcomes. These surgeries typically result in shorter hospitalization and quicker recovery periods, particularly for pediatric patients, making them a preferred choice for both patients and healthcare providers.

Additionally, advancements in the miniaturization of surgical instruments have contributed to the growing demand for robotic-assisted surgeries. Smaller, more efficient robotic tools are allowing surgeons to operate in confined spaces with greater precision, which is especially beneficial for delicate or complex surgeries. The ability to work in smaller, more restricted areas with greater accuracy is expected to continue driving the adoption of robotic surgery systems in North America, further boosting market growth in the region.

Asia Pacific Market Outlook

The Asia Pacific region is projected to experience robust growth in the surgical robots market, with an estimated compound annual growth rate (CAGR) of 14.1% from 2024 to 2030. This growth is largely driven by the region's rapid economic development, particularly in countries such as India, China, Singapore, Indonesia, and Australia. As the GDP of these countries continues to grow, there is a significant increase in healthcare investments, which is expected to drive demand for advanced medical technologies, including robotic-assisted surgical systems.

A key factor contributing to the market growth in Asia Pacific is the rising number of government initiatives aimed at promoting the adoption of advanced healthcare technologies. Many governments in the region are increasingly focused on improving healthcare infrastructure and encouraging healthcare providers to integrate state-of-the-art medical devices and systems. These initiatives are expected to help accelerate the adoption of robotic surgery systems, as healthcare organizations seek to enhance the quality and efficiency of medical procedures.

Overall, the growing healthcare investments and technological advancements in Asia Pacific, coupled with supportive government policies, are set to create a favorable environment for the expansion of the surgical robots market in this region. As more countries in Asia Pacific continue to modernize their healthcare sectors and adopt cutting-edge medical technologies, the demand for robotic-assisted surgeries is anticipated to surge, contributing significantly to the global market growth.

Browse through Grand View Research's Category Medical Devices Industry Research Reports.

  • The global electrophysiology devices market size was estimated at USD 12.9 billion in 2024 and is projected to grow at a CAGR of 15.1% from 2025 to 2030. 
  • The global preclinical CRO market size was valued at USD 5.72 billion in 2023 and is anticipated to grow at a CAGR of 8.7% from 2024 to 2030.

Key Companies & Market Share Insights

Key companies are increasingly focusing on introducing innovative technologies and entering into various strategic collaborations with orthopedic centers & other industry players to acquire new capabilities in surgical robots to maintain their competitive edge. Companies are also undertaking other strategies, such as new product launches and collaborations & partnerships. Moreover, rising demand for automated surgical instruments globally is likely to promote the entry of new companies into the market.

Key Surgical Robots Companies:

  • Intuitive Surgical
  • Medrobotics Corporation
  • Medtronic
  • Renishaw plc
  • Smith and Nephew
  • Stryker Corporation
  • THINK Surgical, Inc.
  • Transenterix (Asensus Surgical, Inc.)
  • Zimmer Biomet

Order a free sample PDF of the Market Intelligence Study, published by Grand View Research.

Comments